Latest News

FDA approves SimpleScreen CRC, Freenome's blood-based colorectal cancer screening test; Abbott to commercialize it in the US this fall.

FDA cleared Roche’s cobas BV/CV assay to detect bacterial vaginosis and Candida vaginitis from a single vaginal swab sample.

Topline TRIUMPH-2 and TRIUMPH-3 results showed retatrutide reduced weight by up to 20.8% in adults with type 2 diabetes and 22.6% in adults with CVD.

The US FDA Fast Track status advances remlifanserin for Alzheimer disease psychosis, with phase 2 RADIANT data expected in fall 2026.

A peer-reviewed study found FDA-cleared IGeneX immunoblot tests detected 58.3% of early Lyme cases vs 30.0% with standard two-tier testing.

Stevan Gonzalez, MD, a transplant specialist, discusses why chronic liver disease often goes undetected and shares practical screening and referral strategies for PCPs.

A new study links semaglutide and tirzepatide to fewer alcohol-related hospitalizations in adults with AUD and diabetes or obesity.

A cross-sectional study linked compulsive smartphone use and limited offline social activity to depressive symptoms in adults aged 60 years or older.